<DOC>
	<DOCNO>NCT01580982</DOCNO>
	<brief_summary>The mechanisms sensitivity resistance oncogene-targeted therapy determine tumor tissue tumor cell line derive available archival sample and/or standard-of-care re-biopsy upon suspected tumor progression .</brief_summary>
	<brief_title>Molecular Analysis Oncogenes Resistance Mechanisms Lung Cancer</brief_title>
	<detailed_description>To identify baseline treatment-related somatic change tumor tissue patient lung thoracic cancer . To estimate proportion patient subsequent therapy alter base information acquire biopsy .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>1 . Patients undergoing investigation treatment thoracic cancer oncogenetargeted therapy 2 . Aged 18 year old 3 . Either ) suspect tumor progression condition dictate standardofcare palliative , therapeutic , diagnostic intervention include limited procedure bronchoscopic biopsy , compute tomography ( CT ) ultrasound ( US ) guide biopsy , thoracentesis , video assist thoracoscopic ( VATS ) pleurodesis , lobectomy , adrenalectomy pleural catheter placement , provide tumor specimen appropriate molecular analysis b ) previously biopsy/surgical intervention tumor tissue University Colorado outside institution available medullar analysis . 4 . Patients must ability understand willingness sign inform consent document .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Oncogenes</keyword>
	<keyword>Lung Other Thoracic Cancers</keyword>
</DOC>